Barriers to clinical trials: Part I: Reimbursement problems

Most of the major clinical advancement in cancer treatment has been provided by cancer clinical trials. Approximately 60% of clinical trials are conducted in the community treatment setting and approximately 40% in academic and cancer centers. The cost of these trials are borne by a combination of t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1994-11, Vol.74 (S9), p.2662-2665
1. Verfasser: Fleming, Irvin D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!